BE640817A - - Google Patents
Info
- Publication number
- BE640817A BE640817A BE640817A BE640817A BE640817A BE 640817 A BE640817 A BE 640817A BE 640817 A BE640817 A BE 640817A BE 640817 A BE640817 A BE 640817A BE 640817 A BE640817 A BE 640817A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US242646A US3272824A (en) | 1962-12-06 | 1962-12-06 | 4-amino-6, 7-di(lower) alkoxyquinolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE640817A true BE640817A (en:Method) | 1964-04-01 |
Family
ID=22915626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE640817A BE640817A (en:Method) | 1962-12-06 | 1963-12-04 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3272824A (en:Method) |
| AT (1) | AT248437B (en:Method) |
| BE (1) | BE640817A (en:Method) |
| BR (1) | BR6355254D0 (en:Method) |
| CH (1) | CH439290A (en:Method) |
| DK (1) | DK107024C (en:Method) |
| ES (1) | ES292176A1 (en:Method) |
| FI (1) | FI41554B (en:Method) |
| GB (1) | GB1010254A (en:Method) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1035777A (en) * | 1963-08-20 | 1966-07-13 | Bellon Labor Sa Roger | Isoquinoline derivatives |
| FR6103M (en:Method) * | 1967-02-22 | 1968-06-10 | ||
| US3502681A (en) * | 1968-04-10 | 1970-03-24 | Roussel Uclaf | 7- or 8-chloro-4-phenylamino-chloroquinolines |
| US3668207A (en) * | 1970-01-22 | 1972-06-06 | Ciba Geigy Corp | 2-amino-4-aryl-quinolines |
| US3856796A (en) * | 1972-04-19 | 1974-12-24 | Sandoz Ag | Hydroxyalkyl-substituted-amino-quinolines and nitrates thereof |
| US4035367A (en) * | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
| GR79603B (en:Method) * | 1982-07-24 | 1984-10-31 | Pfizer | |
| US4771052A (en) * | 1987-02-05 | 1988-09-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Tetrahydropyrido[3',4':4,5]pyrrolo[2,3-c]quinolines and their use as hypotensive agents |
| USRE37650E1 (en) | 1991-05-10 | 2002-04-09 | Aventis Pharmacetical Products, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| US5714493A (en) * | 1991-05-10 | 1998-02-03 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| JPH05213884A (ja) * | 1991-06-14 | 1993-08-24 | Upjohn Co:The | 新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| IL128994A (en) * | 1996-09-25 | 2004-12-15 | Zeneca Ltd | History of quinoline and naphthyridine and their salts, processes for their preparation, pharmaceutical preparations containing them and their use as medicines |
| US6159978A (en) | 1997-05-28 | 2000-12-12 | Aventis Pharmaceuticals Product, Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| WO2002094789A1 (en) * | 2001-05-21 | 2002-11-28 | F. Hoffmann-La Roche Ag | Quinoline derivatives as ligands for the neuropeptide y receptor |
| US6787558B2 (en) * | 2001-09-28 | 2004-09-07 | Hoffmann-La Roche Inc. | Quinoline derivatives |
| US20070197538A1 (en) * | 2004-10-07 | 2007-08-23 | Mark Nesbit | Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors |
| CN108473435A (zh) | 2015-10-05 | 2018-08-31 | 纽约市哥伦比亚大学理事会 | 自噬潮和磷脂酶d的活化剂以及包括tau的蛋白聚集体的清除和蛋白质病的治疗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2555943A (en) * | 1947-06-28 | 1951-06-05 | Sterling Drug Inc | Dihalo-4-(aliphatic tertiaryamino-alkylamino)quinolines |
| US2940976A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-(lower-alkyl)-4-(quaternary-ammonium-alkylimino)-1, 4-dihydroquinolines |
| US2940974A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-substituted-4-[(tertiary-or secondary-amino)-alkylimino]-1, 4-dihydroquinolines |
| US3002001A (en) * | 1958-04-03 | 1961-09-26 | Sterling Drug Inc | 4-alkylimino-1-[aromatic-(lower - alkyl)]-1,4-dihydroquinolines and their preparation |
-
1962
- 1962-12-06 US US242646A patent/US3272824A/en not_active Expired - Lifetime
-
1963
- 1963-10-02 GB GB38781/63A patent/GB1010254A/en not_active Expired
- 1963-10-03 ES ES292176A patent/ES292176A1/es not_active Expired
- 1963-11-29 DK DK559363AA patent/DK107024C/da active
- 1963-12-04 BE BE640817A patent/BE640817A/xx unknown
- 1963-12-04 FI FI2401/63A patent/FI41554B/fi active
- 1963-12-05 CH CH1498063A patent/CH439290A/de unknown
- 1963-12-06 AT AT977363A patent/AT248437B/de active
- 1963-12-06 BR BR155254/63A patent/BR6355254D0/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3272824A (en) | 1966-09-13 |
| BR6355254D0 (pt) | 1973-07-19 |
| DK107024C (da) | 1967-04-17 |
| CH439290A (de) | 1967-07-15 |
| AT248437B (de) | 1966-07-25 |
| GB1010254A (en) | 1965-11-17 |
| ES292176A1 (es) | 1964-02-16 |
| FI41554B (en:Method) | 1969-09-01 |